NORML Delivers 10,369 public comments to the United States FDA in support of descheduling cannabis.
So, the Food and Drug Administration (FDA) was required by the World Health Organization to gather public comments on whether to change marijuana’s classification. Currently considered a drug with no medical use and a high potential for abuse, NORML has turned in more than 10,000 responses to a survey that altar marijuana laws around the globe.
Just dropped off 10,369 public comments to the @US_FDA to have the United States recommend to the @UN @WHO change international treaties when it comes to cannabis. Send a message to your lawmakers about the need for reform NOW at https://t.co/W1O21rytlB pic.twitter.com/FYtdwpvop5— NORML (@NORML) April 23, 2018
In early April 2018, the FDA requested public comments regarding cannabis as a Schedule I drug, grouped with heroin and cocaine, among other drugs. The World Health Organization (WHO) is conducting a review on international prohibition of cannabis and will consider all of the comments gathered by the FDA in the United States, as well as similar bodies in other nations.
